These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24960209)

  • 1. Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: modulator of toxicity of alpha-synuclein aggregates.
    Modi G; Voshavar C; Gogoi S; Shah M; Antonio T; Reith ME; Dutta AK
    ACS Chem Neurosci; 2014 Aug; 5(8):700-17. PubMed ID: 24960209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel multifunctional dopamine D
    Luo D; Sharma H; Yedlapudi D; Antonio T; Reith MEA; Dutta AK
    Bioorg Med Chem; 2016 Nov; 24(21):5088-5102. PubMed ID: 27591013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Pharmacological Characterization of Carbazole Based Dopamine Agonists as Potential Symptomatic and Neuroprotective Therapeutic Agents for Parkinson's Disease.
    Elmabruk A; Das B; Yedlapudi D; Xu L; Antonio T; Reith MEA; Dutta AK
    ACS Chem Neurosci; 2019 Jan; 10(1):396-411. PubMed ID: 30301349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo.
    Das B; Rajagopalan S; Joshi GS; Xu L; Luo D; Andersen JK; Todi SV; Dutta AK
    Neuropharmacology; 2017 Sep; 123():88-99. PubMed ID: 28533164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson's disease animal models.
    Ghosh B; Antonio T; Zhen J; Kharkar P; Reith ME; Dutta AK
    J Med Chem; 2010 Feb; 53(3):1023-37. PubMed ID: 20038106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action.
    Biswas S; Zhang S; Fernandez F; Ghosh B; Zhen J; Kuzhikandathil E; Reith ME; Dutta AK
    J Med Chem; 2008 Jan; 51(1):101-17. PubMed ID: 18072730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Iron(II) Preferring Dopamine Agonist Chelator as Potential Symptomatic and Neuroprotective Therapeutic Agent for Parkinson's Disease.
    Das B; Kandegedara A; Xu L; Antonio T; Stemmler T; Reith MEA; Dutta AK
    ACS Chem Neurosci; 2017 Apr; 8(4):723-730. PubMed ID: 28106982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson's disease with dementia.
    Yedlapudi D; Xu L; Luo D; Marsh GB; Todi SV; Dutta AK
    Sci Rep; 2019 Dec; 9(1):19648. PubMed ID: 31873106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-512, a novel dopamine D
    Lindenbach D; Das B; Conti MM; Meadows SM; Dutta AK; Bishop C
    Br J Pharmacol; 2017 Sep; 174(18):3058-3071. PubMed ID: 28667675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Highly Potent D2/D3 Agonist and a Partial Agonist from Structure-Activity Relationship Study of N(6)-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson's Disease.
    Das B; Vedachalam S; Luo D; Antonio T; Reith ME; Dutta AK
    J Med Chem; 2015 Dec; 58(23):9179-95. PubMed ID: 26555041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity.
    Biswas S; Hazeldine S; Ghosh B; Parrington I; Kuzhikandathil E; Reith ME; Dutta AK
    J Med Chem; 2008 May; 51(10):3005-19. PubMed ID: 18410082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcorynoline attenuates dopaminergic neuron degeneration and α-synuclein aggregation in animal models of Parkinson's disease.
    Fu RH; Wang YC; Chen CS; Tsai RT; Liu SP; Chang WL; Lin HL; Lu CH; Wei JR; Wang ZW; Shyu WC; Lin SZ
    Neuropharmacology; 2014 Jul; 82():108-20. PubMed ID: 23973292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease.
    Finkelstein DI; Billings JL; Adlard PA; Ayton S; Sedjahtera A; Masters CL; Wilkins S; Shackleford DM; Charman SA; Bal W; Zawisza IA; Kurowska E; Gundlach AL; Ma S; Bush AI; Hare DJ; Doble PA; Crawford S; Gautier EC; Parsons J; Huggins P; Barnham KJ; Cherny RA
    Acta Neuropathol Commun; 2017 Jun; 5(1):53. PubMed ID: 28659169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship study of N⁶-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: development of highly selective D3 dopamine receptor agonists along with a highly potent D2/D3 agonist and their pharmacological characterization.
    Johnson M; Antonio T; Reith ME; Dutta AK
    J Med Chem; 2012 Jun; 55(12):5826-40. PubMed ID: 22642365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.
    Richter F; Gao F; Medvedeva V; Lee P; Bove N; Fleming SM; Michaud M; Lemesre V; Patassini S; De La Rosa K; Mulligan CK; Sioshansi PC; Zhu C; Coppola G; Bordet T; Pruss RM; Chesselet MF
    Neurobiol Dis; 2014 Sep; 69():263-75. PubMed ID: 24844147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.
    Castro-Hernández J; Afonso-Oramas D; Cruz-Muros I; Salas-Hernández J; Barroso-Chinea P; Moratalla R; Millan MJ; González-Hernández T
    Neurobiol Dis; 2015 Feb; 74():325-35. PubMed ID: 25511804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Protective Role of Multifunctional Dopamine Agonist D-512 Against Oxidative Stress Produced by Depletion of Glutathione in PC12 Cells: Implication in Neuroprotective Therapy for Parkinson's Disease.
    Voshavar C; Shah M; Xu L; Dutta AK
    Neurotox Res; 2015 Nov; 28(4):302-18. PubMed ID: 26201265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson's disease.
    Ghosh B; Antonio T; Reith ME; Dutta AK
    J Med Chem; 2010 Mar; 53(5):2114-25. PubMed ID: 20146482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease.
    Shah M; Rajagopalan S; Xu L; Voshavar C; Shurubor Y; Beal F; Andersen JK; Dutta AK
    J Neurochem; 2014 Oct; 131(1):74-85. PubMed ID: 24848702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's disease.
    Jones CA; Johnston LC; Jackson MJ; Smith LA; van Scharrenburg G; Rose S; Jenner PG; McCreary AC
    Eur Neuropsychopharmacol; 2010 Aug; 20(8):582-93. PubMed ID: 20434890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.